# Advanced Development of Vaccines for Influenza

> **NIH NIH N01** · GREFFEX, INC. · 2024 · $1,256,003

## Abstract

To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation. Current efforts include a Phase I/II clinical trial.

## Key facts

- **NIH application ID:** 11082177
- **Project number:** 75N93019C00061-P00022-9999-1
- **Recipient organization:** GREFFEX, INC.
- **Principal Investigator:** UWE STAERZ
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,256,003
- **Award type:** —
- **Project period:** 2019-09-09 → 2026-02-08

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11082177

## Citation

> US National Institutes of Health, RePORTER application 11082177, Advanced Development of Vaccines for Influenza (75N93019C00061-P00022-9999-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11082177. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*